Literature DB >> 35121882

The next generation of DNMT inhibitors.

Parinaz Mehdipour1, Raymond Chen1,2, Daniel D De Carvalho3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 35121882     DOI： 10.1038/s43018-021-00271-z

Source DB:  PubMed          Journal:  Nat Cancer        ISSN： 2662-1347


× No keyword cloud information.
  2 in total

1.  Lnc'ing Metabolic Regulation of Epigenetic Modifications to Atherosclerotic Calcification.

Authors:  Rolando A Cuevas; Cynthia St Hilaire
Journal:  Circ Res       Date:  2022-05-12       Impact factor: 23.213

Review 2.  PARP inhibitors as single agents and in combination therapy: the most promising treatment strategies in clinical trials for BRCA-mutant ovarian and triple-negative breast cancers.

Authors:  Linjie Luo; Khandan Keyomarsi
Journal:  Expert Opin Investig Drugs       Date:  2022-05-03       Impact factor: 6.498
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.